Nectar Lifesciences Ltd (NECLIFE):企業の財務・戦略的SWOT分析

◆英語タイトル:Nectar Lifesciences Ltd (NECLIFE) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15137
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nectar Lifesciences Ltd (NecLife) is a research driven pharmaceutical company that manufactures active pharmaceutical ingredients (APIs). The company provides contract research and manufacturing services such as process development and optimization, process scale up and validation, multi kilo pilot plant production, bulk production and chiral resolution, among others. It offers products such as API’s, generics and over the counter drugs, empty hard gelatin capsules and menthol. NecLife also provides invitro diagnostic products through its specialty division, Necpath. The company offers contract manufacturing services for the formulations such as tablets, capsules, dry powder oral suspension and granules and injectibles for cephalosporins, and others. It has business presence across China, South Africa, India, Korea, Russia and Brazil. NecLife is headquartered in Chandigarh, Haryana, India.

Nectar Lifesciences Ltd Key Recent Developments

Feb 28,2019: Nectar Lifesciences announces resignation of director
Jun 28,2018: Nectar Lifesciences Announces Change in Directorate
May 28,2018: Nectar Lifesciences Reports Revenue From Operations Of INR19 Billion In Fiscal 2018

This comprehensive SWOT profile of Nectar Lifesciences Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Nectar Lifesciences Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Nectar Lifesciences Ltd – Key Information
Nectar Lifesciences Ltd – Overview
Nectar Lifesciences Ltd – Key Employees
Nectar Lifesciences Ltd – Key Employee Biographies
Nectar Lifesciences Ltd – Key Operational Heads
Nectar Lifesciences Ltd – Major Products and Services
Nectar Lifesciences Ltd – History
Nectar Lifesciences Ltd – Company Statement
Nectar Lifesciences Ltd – Locations And Subsidiaries
Nectar Lifesciences Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Nectar Lifesciences Ltd – Business Description
Nectar Lifesciences Ltd – Corporate Strategy
Nectar Lifesciences Ltd – SWOT Analysis
SWOT Analysis – Overview
Nectar Lifesciences Ltd – Strengths
Nectar Lifesciences Ltd – Weaknesses
Nectar Lifesciences Ltd – Opportunities
Nectar Lifesciences Ltd – Threats
Nectar Lifesciences Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Nectar Lifesciences Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Nectar Lifesciences Ltd, Key Information
Nectar Lifesciences Ltd, Key Ratios
Nectar Lifesciences Ltd, Share Data
Nectar Lifesciences Ltd, Major Products and Services
Nectar Lifesciences Ltd, History
Nectar Lifesciences Ltd, Key Employees
Nectar Lifesciences Ltd, Key Employee Biographies
Nectar Lifesciences Ltd, Key Operational Heads
Nectar Lifesciences Ltd, Other Locations
Nectar Lifesciences Ltd, Subsidiaries
Nectar Lifesciences Ltd, Key Manufacturing facilities
Nectar Lifesciences Ltd, Key Competitors
Nectar Lifesciences Ltd, SWOT Analysis
Nectar Lifesciences Ltd, Ratios based on current share price
Nectar Lifesciences Ltd, Annual Ratios
Nectar Lifesciences Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Nectar Lifesciences Ltd, Performance Chart
Nectar Lifesciences Ltd, Ratio Charts

★海外企業調査レポート[Nectar Lifesciences Ltd (NECLIFE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wegmans Food Markets, Inc.:企業の戦略・SWOT・財務分析
    Wegmans Food Markets, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wegmans Food Markets, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Banco de Sabadell SA:企業のM&A・事業提携・投資動向
    Banco de Sabadell SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco de Sabadell SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Accugenomics Inc-医療機器分野:企業M&A・提携分析
    Summary Accugenomics Inc (Accugenomics) is a provider of molecular diagnostics for cancer. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test …
  • McBride plc (MCB):企業の財務・戦略的SWOT分析
    McBride plc (MCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Investcorp Bank BSc (INVCORP):企業の財務・戦略的SWOT分析
    Investcorp Bank BSc (INVCORP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • K S Oils Limited:戦略・SWOT・企業財務分析
    K S Oils Limited - Strategy, SWOT and Corporate Finance Report Summary K S Oils Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • China Vanke Co., Ltd.:企業の戦略・SWOT・財務情報
    China Vanke Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary China Vanke Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cogstate Ltd (CGS):企業の財務・戦略的SWOT分析
    Summary Cogstate Ltd (Cogstate) is a cognitive science company that provides technology solutions. The company offers scientific consulting, precision recruitment and computerized assessment, among others. It also provides drug development strategies, protocol design, test selection for screening, s …
  • TechnipFMC Plc (FTI):企業の財務・戦略的SWOT分析
    TechnipFMC Plc (FTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sysco Corporation:企業の戦略・SWOT・財務情報
    Sysco Corporation - Strategy, SWOT and Corporate Finance Report Summary Sysco Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Bukwang Pharm Co Ltd (003000):製薬・医療:M&Aディール及び事業提携情報
    Summary Bukwang Pharm Co Ltd (Bukwang Pharmaceutical) is a pharmaceutical company that develops new drugs and pharmaceutical products. The company’s products portfolio includes dexid, thioctacid, levovir, legalon, Orfil, azeptin, lonasen, ixel, and asima, among others. Its pipeline products comprise …
  • Novartis AG (NOVN):製薬・医療:M&Aディール及び事業提携情報
    Summary Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products. It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, n …
  • Dicerna Pharmaceuticals Inc (DRNA):企業の財務・戦略的SWOT分析
    Summary Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that offers therapies. The company discovers and develops treatments for rare inherited diseases including liver and for cancers that are genetically defined. It offers RNAi technology platform GalXCTM, which is a advances …
  • Extreme Networks Inc (EXTR):企業の財務・戦略的SWOT分析
    Extreme Networks Inc (EXTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Camlin Fine Sciences Ltd:企業の戦略・SWOT・財務情報
    Camlin Fine Sciences Ltd - Strategy, SWOT and Corporate Finance Report Summary Camlin Fine Sciences Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ClearStream Energy Services Inc:企業の戦略・SWOT・財務情報
    ClearStream Energy Services Inc - Strategy, SWOT and Corporate Finance Report Summary ClearStream Energy Services Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • IntelliCell BioSciences Inc:企業の戦略的SWOT分析
    IntelliCell BioSciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Asatsu-DK Inc.:企業の戦略的SWOT分析
    Asatsu-DK Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Genoptix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genoptix Inc (Genoptix) is a hematopathology center which provides oncology diagnostics and informatics services specializing in hematology and solid tumors. The center offers biopharma and healthcare laboratory, discovery, drug development, care and cost development, and patient services. G …
  • Toyota Motor Corp (7203):電力:M&Aディール及び事業提携情報
    Summary Toyota Motor Corp (Toyota) is a manufacturer of automobiles. It designs, manufactures, assembles and sells passenger cars, minivans, recreational and sport-utility vehicles, commercial vehicles such as trucks and related parts and accessories. It also manufactures crafts, and finances its de …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆